Blood Pressure and ADRD in African Americans: the Jackson Heart Study
非裔美国人的血压和 ADRD:杰克逊心脏研究
基本信息
- 批准号:10165457
- 负责人:
- 金额:$ 155.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAfrican AmericanAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer’s disease biomarkerAmbulatory Blood Pressure MonitoringAmerican Heart AssociationAmyloidAncillary StudyBiological FactorsBiological MarkersBlood PressureBlood VesselsBrainCardiologyCardiovascular DiseasesCardiovascular systemCerebrovascular DisordersClassificationClinicalClinical TrialsCognitionCognitiveCohort StudiesComplementCoupledDataDementiaDetectionDiagnosisDiastolic blood pressureElderlyExposure toFailureGeneticGenotypeGoalsGuidelinesHigh PrevalenceHourHypertensionImpaired cognitionIndividualIntervention TrialJackson Heart StudyJointsLightMagnetic Resonance ImagingMeasuresMediatingMediator of activation proteinMemoryMinority GroupsNational Institute on AgingNerve DegenerationOutcomeParticipantPathologyPhenotypePlasmaPopulation HeterogeneityPrevalencePreventionRaceReadingRecommendationReportingResearchRiskRoleSpecific qualifier valueTimeUpdateWhite Matter HyperintensityWomanadjudicationaging brainapolipoprotein E-4blood pressure interventionblood pressure reductionblood pressure variabilitybrain healthbrain volumecerebrovascular pathologycognitive functioncognitive performancecognitive testingcohortcollegedementia riskearly onsetethnic differencefollow-upgenetic risk factorgenetic varianthealth disparityhigh riskimprovedinnovationmeetingsmembermild cognitive impairmentminority healthneurofilamentneuropathologynovelpolicy implicationprimary outcomeracial disparityresilienceresponsesecondary outcomesexsocial health determinantssymposiumtau Proteinsvascular risk factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Rates of mild cognitive impairment (MCI) and dementia are two to three times higher among African Americans
(AAs) than among White older adults. Observational and clinical trial data, most recently from the Systolic
Blood Pressure Intervention Trial: Memory and Cognition in Decreased Hypertension (SPRINT-MIND), support
that blood pressure is the most important modifiable vascular risk factor for MCI and dementia. However, the
short duration of follow-up in SPRINT-MIND coupled with the failure to detect a statistically significant benefit of
a lower blood pressure goal for incident dementia means that longer-term observational data will be necessary
to fully address the implications of the clinical trial results. These questions are particularly salient for AAs, who
have earlier onset of high blood pressure and are at higher risk of dementia, in particular cerebrovascular
pathology. Even after considering race/ethnic differences in blood pressure level, the mechanisms underlying
racial disparities in risk for dementia are not well understood. Additionally, despite facing a high burden of high
blood pressure, some individuals are resilient, achieving better-than-expected outcomes. The specific factors
that contribute to brain-health resilience are not well established. We propose to address these research gaps
in an ancillary study to the 2020-2022 4th examination of ~2,700 participants in the Jackson Heart Study (JHS),
an ongoing cohort study of well-characterized AAs. The JHS Exam 4 will include brain magnetic resonance
imaging (MRI) data to ascertain cerebrovascular disease and neurodegeneration. We propose to add
measures of cognition and function sufficient for classification of MCI and dementia, and innovative plasma
biomarkers of amyloid (Ab42, Ab40), tau, and neurodegeneration (neurofilament light). The primary aims are
as follows: Aim 1. Estimate the long-term associations of exposure to high 20-year time-weighted average
blood pressure and blood pressure load on (1) cognitive performance; (2) prevalence of MCI and dementia; (3)
markers of cerebrovascular disease and neurodegeneration quantified from MRI; and (4) plasma amyloid, tau
and neurodegeneration. Aim 2. Examine whether sex, educational quality (i.e. reading level measured with the
WRAT), and APOE-e4 and ABCA7 genotype, modify the associations of long-term exposure to high blood
pressure and blood pressure load with cognitive outcomes. This study is responsive to PAR-19-070 and NOT-
AG-18-047 (Health Disparities and Alzheimer’s Disease) by adding cognitive assessments to a landmark
cohort study of cardiovascular disease in AAs; leveraging existing and new data to understand risk and
resilience factors for cognitive impairment; and drawing on the JHS cohort to understand vascular mechanisms
underlying cognitive impairment in a minority population. This study is also proposed in the context of the
updated National Institute on Aging/Alzheimer’s Association research framework in which the constructs of
amyloid, tau, and neurodegeneration are featured prominently. Lastly, results from this study will inform future
research and have implications for policies intended to improve brain aging in minority populations.
项目概要/摘要
非裔美国人轻度认知障碍 (MCI) 和痴呆症的发病率高出两到三倍
(AA)高于白人老年人的观察和临床试验数据,最近来自收缩期。
血压干预试验:降低高血压的记忆和认知 (SPRINT-MIND),支持
血压是 MCI 和痴呆症最重要的可改变血管危险因素。
SPRINT-MIND 的随访时间较短,并且未能检测到统计上显着的益处
针对痴呆症的较低血压目标意味着需要长期观察数据
充分解决临床试验结果的影响,这些问题对于 AA 来说尤其突出。
高血压发病较早,患痴呆症的风险较高,尤其是脑血管病
即使考虑了血压水平的种族/民族差异,其背后的机制也是如此。
此外,尽管面临着高负担,但痴呆症风险的种族差异尚不清楚。
血压,一些人有弹性,取得了比预期更好的结果。
我们建议弥补这些研究空白。
在杰克逊心脏研究 (JHS) 的 2,700 名参与者参加的 2020-2022 年第四次检查的辅助研究中,
正在进行的一项针对特征明确的 AA 的队列研究将包括脑磁共振。
我们建议添加用于确定脑血管疾病和神经退行性疾病的成像(MRI)数据。
足以对 MCI 和痴呆进行分类的认知和功能测量,以及创新血浆
淀粉样蛋白(Ab42、Ab40)、tau 蛋白和神经变性(神经丝光)的生物标志物主要目标是。
如下: 目标 1. 估计与 20 年时间加权平均值较高的风险敞口的长期关联
血压和血压负荷对 (1) 认知能力的影响;(2) MCI 和痴呆的患病率;
通过 MRI 定量脑血管疾病和神经退行性变的标志物;以及 (4) 血浆淀粉样蛋白、tau 蛋白
目标 2. 检查性别、教育质量(即阅读水平)是否与
WRAT)以及 APOE-e4 和 ABCA7 基因型,改变了长期暴露于高血脂的关联
压力和血压负荷与认知结果的关系 本研究响应 PAR-19-070 和 NOT-。
AG-18-047(健康差异和阿尔茨海默病)通过在里程碑中添加认知评估
AA 中心血管疾病的队列研究队列;利用现有数据和新数据来了解风险和风险
认知障碍的恢复力因素;并利用 JHS 队列来了解血管机制
这项研究也是在少数群体中潜在的认知障碍的背景下提出的。
更新了国家老龄化研究所/阿尔茨海默氏症协会的研究框架,其中的构建
最后,这项研究的结果将为未来提供信息。
研究并对旨在改善少数群体大脑老化的政策产生影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Priya Palta其他文献
Priya Palta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Priya Palta', 18)}}的其他基金
Physical activity, physical function, and frailty in relation to cognitive impairment and AD/ADRD biomarkers in DPPOS
DPPOS 中与认知障碍和 AD/ADRD 生物标志物相关的体力活动、身体功能和虚弱
- 批准号:
10507637 - 财政年份:2022
- 资助金额:
$ 155.49万 - 项目类别:
Physical Activity and Preservation of Cognitive Function
体力活动和认知功能的保护
- 批准号:
10302710 - 财政年份:2020
- 资助金额:
$ 155.49万 - 项目类别:
Physical Activity and Preservation of Cognitive Function
体力活动和认知功能的保护
- 批准号:
10160748 - 财政年份:2019
- 资助金额:
$ 155.49万 - 项目类别:
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
非裔美国人的血压和 ADRD:杰克逊心脏研究
- 批准号:
10425351 - 财政年份:2019
- 资助金额:
$ 155.49万 - 项目类别:
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
非裔美国人的血压和 ADRD:杰克逊心脏研究
- 批准号:
10836272 - 财政年份:2019
- 资助金额:
$ 155.49万 - 项目类别:
Physical Activity and Preservation of Cognitive Function
体力活动和认知功能的保护
- 批准号:
9981560 - 财政年份:2019
- 资助金额:
$ 155.49万 - 项目类别:
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
非裔美国人的血压和 ADRD:杰克逊心脏研究
- 批准号:
10018630 - 财政年份:2019
- 资助金额:
$ 155.49万 - 项目类别:
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
非裔美国人的血压和 ADRD:杰克逊心脏研究
- 批准号:
9891658 - 财政年份:2019
- 资助金额:
$ 155.49万 - 项目类别:
Physical Activity and Preservation of Cognitive Function
体力活动和认知功能的保护
- 批准号:
9179929 - 财政年份:2016
- 资助金额:
$ 155.49万 - 项目类别:
Physical Activity and Preservation of Cognitive Function
体力活动和认知功能的保护
- 批准号:
9340058 - 财政年份:2016
- 资助金额:
$ 155.49万 - 项目类别:
相似海外基金
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 155.49万 - 项目类别:
Exploring the Impact of Genetic Ancestry on Acute Lymphoblastic Leukemia Risk in Latino Populations
探索遗传血统对拉丁裔人群急性淋巴细胞白血病风险的影响
- 批准号:
10607300 - 财政年份:2023
- 资助金额:
$ 155.49万 - 项目类别:
Discovery of Immunogenomic Associations with Disease and Differential Risk Across Diverse Populations
发现免疫基因组与不同人群的疾病和差异风险的关联
- 批准号:
10796657 - 财政年份:2023
- 资助金额:
$ 155.49万 - 项目类别:
Evaluating the clinical implications for ACKR1/DARC associated neutropenia
评估 ACKR1/DARC 相关中性粒细胞减少症的临床意义
- 批准号:
10754130 - 财政年份:2023
- 资助金额:
$ 155.49万 - 项目类别: